Expression screening of 17q12–21 amplicon reveals GRB7 as an ERBB2‐dependent oncogene
Makoto Saito(Broad Institute), Shinya Watanabe(Fukushima Medical University), Emi Ito(Fukushima Medical University), Hiromi Mochizuki(Japan Biological Informatics Consortium), Kentaro Semba(Fukushima Medical University), Yuka Yanagisawa(Fukushima Medical University), Yoshifumi Kawamura(Japan Biological Informatics Consortium), Atsuka Matsui(Waseda University), Naoki Goshima(National Institute of Advanced Industrial Science and Technology), Sakura Azuma(Waseda University), Jiro Fujimoto(Hyogo Medical University), Kentaro Kumazawa(Waseda University), Ayano Doi(Waseda University), Shiori Takebe(Waseda University), Hirokazu Ohbayashi, Kosuke Ishikawa(Waseda University), Takaomi Ishida(Denka (Japan)), Yukiko Kato(Kyoto University), Reiko Honma(Fukushima Medical University), Jun-ichi Imai(Fukushima Medical University)
Cited by 30
Related Papers
Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing
|New England Journal of Medicine|2020|801
Identification of TRAF6, a Novel Tumor Necrosis Factor Receptor-associated Factor Protein That Mediates Signaling from an Amino-terminal Domain of the CD40 Cytoplasmic Region
|Journal of Biological Chemistry|1996|478
Point-of-care testing for COVID-19 using SHERLOCK diagnostics
|medRxiv|2020|336
Acetylation of intrinsically disordered regions regulates phase separation
|Nature Chemical Biology|2018|301
Structural insights into HDAC6 tubulin deacetylation and its selective inhibition
|Nature Chemical Biology|2016|295